Immune to Cancer: The CRI Blog
-
Why We Give: Real Stories of Hope, Loss, and the Drive to a Future #Immune2Cancer
What drives someone to fund cancer research? At the Cancer Research Institute (CRI), the answers are as… -
Immuno-Oncology 2025: Expert Panel Weighs in on AI, Cell Therapy and Clinical Breakthroughs
We are excited to share 8 key takeaways from a recent ‘State of Immuno-Oncology’ webinar featuring a… -
Introducing CRI’s 2025 Cancer Immunotherapy Insights + Impact Report: Evolution of Immunotherapy, FDA Approvals & Next-Generation Treatment Trends
As a scientist who has spent the better part of my career thinking about the prevention, diagnosis,… -
2025 AACR-CRI Lloyd J. Old Award: Dr. Crystal Mackall Honored for Fearlessly Confronting the “Beast” of Cancer
The Cancer Research Institute (CRI) and the American Association for Cancer Research (AACR) have awarded Dr. Crystal… -
Immunotherapy vs. Chemotherapy: What’s the Difference?
We answer common questions patients ask about how immunotherapy compares to chemotherapy, including side effects and length…
-
Fighting Colorectal Cancer with Immunotherapy: What You Need to Know
While colorectal cancer (CRC) is the third most diagnosed cancer and the third leading cause of cancer… -
Saving Research, Saving Lives: Fighting for the Future of Cancer Science Amid NIH Disruptions
At the Cancer Research Institute (CRI), we recognize the National Institutes of Health (NIH) as a cornerstone… -
Riding Through It: How Immunotherapy and His Bike Helped Thomas Vibert Beat Stage 4 Colon Cancer
March is Colorectal Cancer Awareness Month, a time to spotlight perseverance, advocacy, and groundbreaking treatments like immunotherapy…. -
“We’ve Always Been Here” – A Personal Reflection on Female Scientists for Women’s History Month
This March, I’d like to take a moment to reflect on, acknowledge, and amplify the contributions of…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.